Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.025 | 0.9 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0037 | 0.9 |